Lisata Therapeutics LSTA
NASDAQ LSTA
$1.49 +0.05 (+3.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Beginning Cash Balance (2011 - 2013)

Updated

Lisata Therapeutics' Beginning Cash Balance came in at $46.13 million for Q4 2013, up 235.8% from $13.74 million a year earlier.

Analysis

Lisata Therapeutics (LSTA) Beginning Cash Balance (2011 - 2013) Analysis & Trends

  • Going back by year, Beginning Cash Balance was $13.74 million in FY2012 (+7.8%) and $12.75 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lisata Therapeutics 13.13 Mn 12.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 46.13 Mn
Dec 31, 2012 13.74 Mn
Dec 31, 2011 12.75 Mn
API Access

Lisata Therapeutics Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=LSTA&period=max&api_key=YOUR_API_KEY